Calcineurin inhibitor effects on growth and phenotype of human airway epithelial cells in vitro

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2660-2670

  Neuringer, Isabel P ^a   Sloan, Jessica ^a   Budd, Steven ^a   Chalermskulrat, Worakij ^a   Park, Richard C W ^a   Stonebraker, Jaclyn R ^a   O'Neal, Wanda K ^a   Aris, Robert M ^a   Randell, Scott H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchiolitis obliterans syndrome; Calcineurin inhibitor; Cyclosporin; Human tracheobronchial epithelium; Tacrolimus

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOPHILIN B; CYCLOSPORIN A; DNA; FK 506 BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; LACTATE DEHYDROGENASE; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; CYCLOSPORIN;

ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHUS MUCOSA; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CILIATED EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; LUNG TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRACHEA MUCOSA; TRACHEOBRONCHIAL EPITHELIUM; BIOLOGICAL MODEL; BRONCHUS; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; TRACHEA;

BRONCHI; CALCINEURIN; CELL DIVISION; CELLS, CULTURED; CYCLOSPORINE; HUMANS; LUNG TRANSPLANTATION; MODELS, BIOLOGICAL; PHENOTYPE; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRACHEA;

EID: 33644801226     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01071.x     Document Type: Article

References (61)

1. Trulock EP Edwards LB Taylor DO et al. The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report-2003. J Heart Lung Transplant 2003 22 ( 6 625 635.
2. Estenne M Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002 166 ( 4 440 444.
3. Stewart KC Patterson GA. Current trends in lung transplantation. Am J Transplant 2001 1 ( 3 204 210.
4. Ruhlmann A Nordheim A. Effects of immunosuppressive drugs CsA and FK506 on intracellular signaling and gene regulation. Immunobiology 1997 198: 192 206.
5. Liu J Farmer JD Jr. Lane WS Friedman J Weissman I Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991 66 ( 4 807 815.
6. Andoh TF Bennett WM. Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 1998 7 ( 3 265 270.
7. de Mattos AM Olyaei AJ Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 2000 35 ( 2 333 346.
8. Lally C Healy E Ryan MP. Cyclosporine A-induced cell cycle arrest and cell death in renal epithelial cells. Kidney Int 1999 56 ( 4 1254 1257.
9. Esposito C Fornoni A Cornacchia F et al. Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int 2000 58 ( 1 123 130.
10. Shihab FS Andoh TF Tanner AM et al. Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996 49 ( 4 1141 1151.
11. Borger P Kauffman HF Timmerman JA Scholma J van den Berg JW Koeter GH. Cyclosporine, FK506, mycophenolate mofetil and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. Transplantation 2000 69 ( 7 1408 1413.
12. Zhang JG Walmsley MW Moy JV. Differential effects of cyclosporin A and tacrolimus on the production of TGFβ: implications for the development of obliterative bronchiolitis after lung transplantation. Transpl Int 1998 11S1: S325 S327.
13. Hostettler KE Roth M Burgess JK et al. Cyclosporine A mediates fibroproliferation through epithelial cells. Transplantation 2004 77 ( 12 1886 1893.
14. Neuringer IP Aris RM Burns KA Bartolotta TL Chalermskulrat W Randell SH. Epithelial kinetics in mouse heterotopic tracheal allografts. Am J Transplant 2002 2: 410 419.
15. Bernacki SH Nelson AL Abdullah L et al. Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol 1999 20 ( 4 595 604.
16. Neuringer IP Walsh SP Mannon RB Gabriel S Aris RM. Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis. Transplantation 2000 69 ( 3 399 405.
17. Mohamed MA Robertson H Booth TA et al. TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. Transplantation 2000 69 ( 5 1002 1005.
18. Johnson DW Saunders HJ Johnson FJ et al. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1 and platelet-derived growth factor. J Pharmacol Exp Ther 1999 289 ( 1 535 542.
19. Khanna AK Cairns VR Becker CG et al. Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine. Transplantation 1999 67 ( 6 882 889.
20. Duymelinck C Deng JT Dauwe SE et al. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int 1998 54 ( 3 804 818.
21. Hodge S Hodge G Flower R Reynolds PN Scicchitano R Holmes M. Up-regulation of production of TGF-beta and IL-4 and down-regulation of IL-6 by apoptotic human bronchial epithelial cells. Immunol Cell Biol 2002 80 ( 6 537 543.
22. Gourishankar S Halloran PF. Late deterioration of organ transplants: a problem in injury and homeostasis. Curr Opin Immunol 2002 14 ( 5 576 583.
23. Sayegh MH Remuzzi G ( eds Current and Future Immunosuppressive Therapies following Transplantation 2001. Dordrecht, The Netherlands.
24. Morton JM Aboyoun CL Malouf MA Plit ML Glanville AR. Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation. J Heart Lung Transplant 2004 23 ( 9 1035 1039.
25. McMaster P Mirza DF Ismail T Vennarecci G Patapis P Mayer AD. Therapeutic drug monitoring of tacrolimus in clinical transplantation. Ther Drug Monit 1995 17 ( 6 602 605.
26. Halloran PF Kung L Noujaim J. Calcineurin and the biological effect of cyclosporine and tacrolimus. Transplant Proc. 1998 30 ( 5 2167 2170.
27. Hong F Lee J Piao YJ et al. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity. Biochem Biophys Res Commun 2004 316 ( 4 1073 1080.
28. Price ER Jin M Lim D Pati S Walsh CT McKeon FD. Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci U.S.A. 1994 91 ( 9 3931 3935.
29. Lu KP. Phosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism. Prog Cell Cycle Res 2000 4: 83 96.
30. Shaw PE. Peptidyl-prolyl isomerases: a new twist to transcription. EMBO Rep 2002 3 ( 6 521 526.
31. Hong F Lee J Song JW et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 2002 16 ( 12 1633 1635.
32. Kay JE. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Biochem J 1996 314 ( Pt 2 361 385.
33. Wochnik GM Ruegg J Abel GA Schmidt U Holsboer F Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 2005 280 ( 6 4609 4616.
34. Okadome T Oeda E Saitoh M et al. Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo. J Biol Chem 1996 271 ( 36 21687 21690.
35. Azizian M Ramenaden ER Shah G Wilasrusmee C Bruch D Kittur DS. Augmentation of ischemia/reperfusion injury to endothelial cells by cyclosporin A. Am Surg 2004 70 ( 5 438 442.
36. Kochi S Takanaga H Matsuo H Naito M Tsuruo T Sawada Y. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. Eur J Pharmacol 1999 372 ( 3 287 295.
37. Esposito C Foschi A Parrilla B et al. Effect of calcineurin inhibitors on extracellular matrix turnover in isolated human glomeruli. Transplant Proc 2004 36 ( 3 695 697.
38. Polastri L Galbiati F Bertuzzi F et al. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol 2002 39 ( 4 229 233.
39. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 2003 284 ( 4 L566 577.
40. Elssner A Jaumann F Dobmann S et al. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation 2000 70 ( 2 362 367.
41. Holschermann H Rascher C Oelschlager C et al. Opposite regulation of tissue factor expression by calcineurin in monocytes and endothelial cells. J Immunol 2001 166 ( 12 7112 7120.
42. Fukuoka M Ogino Y Sato H Ohta T Komoriya K. Regulation of RANTES and IL-8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol). Br J Pharmacol 1998 124 ( 7 1433 1438.
43. Kehlen A Thiele K Riemann D Langner J. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol 2002 127 ( 3 539 546.
44. Murakami R Kambe F Mitsuyama H et al. Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2003 23 ( 11 2034 2040.
45. Zipfel PF Bialonski A Skerka C. Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A. Biochem Biophys Res Commun 1991 181 ( 1 179 183.
46. Kuhns DB Young HA Gallin EK Gallin JI. Ca2+-dependent production and release of IL-8 in human neutrophils. J Immunol 1998 161 ( 8 4332 4339.
47. Won YH Sauder DN McKenzie RC. Cyclosporin A inhibits keratinocyte cytokine gene expression. Br J Dermatol 1994 130 ( 3 312 319.
48. Sakamoto H Sakamaki T Kanda T et al. Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells. Res Commun Mol Pathol Pharmacol 1997 97 ( 1 60 66.
49. Saitoh O Matsuse R Sugi K et al. Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29). J Gastroenterol 1997 32 ( 5 605 610.
50. Li J Kartha S Iasvovskaia S et al. Regulation of human airway epithelial cell IL-8 expression by MAP kinases. Am J Physiol Lung Cell Mol Physiol 2002 283 ( 4 L690 699.
51. Nakamura H Yoshimura K Jaffe HA Crystal RG. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 1991 266 ( 29 19611 19617.
52. Becker MN Diamond G Verghese MW Randell SH. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 2000 275 ( 38 29731 29736.
53. Esposito C Fornoni A Cornacchia F et al. Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int 2000 58 ( 1 123 130.
54. Yang CW Faulkner GR Wahba IM et al. Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice. Am J Transplant 2002 2 ( 5 391 399.
55. Justo P Lorz C Sanz A Egido J Ortiz A. Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 2003 14 ( 12 3072 3080.
56. Bakker RC van Kooten C van de Lagemaat-Paape ME Daha MR Paul LC. Renal tubular epithelial cell death and cyclosporin A. Nephrol Dial Transplant 2002 17 ( 7 1181 1188.
57. Halloran PF. Mechanism of action of the calcineurin inhibitors. Transplant Proc 2001 33 ( 7-8 3067 3069.
58. Barnes PJ. Current and future therapies for airway mucus hypersecretion. Novartis Found Symp 2002 248: 237 249 discussion 249-53, 277-82.
59. Nadel JA. Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res 2001 2 ( 2 85 89.
60. Burgel PR Nadel JA. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004 59 ( 11 992 996.
61. Yang CW Lee SH Lim SW et al. Cyclosporine or FK506 decrease mature epidermal growth factor protein expression and renal tubular regeneration in rat kidneys with ischemia/reperfusion injury. Nephron 2002 92 ( 4 914 921.